Sign in

CIK 0001649989

  • Non-accelerated filer
  • Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
383982704
Phone
+1 609-619-3990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-06-08 GMS Tenshi Holdings Pte. Ltd Director Grant or award · Warrants +10,256,410 $0.13 $1.3M 20,512,820
2018-05-14 GMS Tenshi Holdings Pte. Ltd Director Grant or award +6,377,383 $0.98 $6.2M 6,377,383
2018-05-14 GMS Tenshi Holdings Pte. Ltd Director Grant or award · Warrants +10,256,410 $0.13 $1.3M 10,256,410
2018-04-13 THURMAN RANDY H Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2018-03-31 GMS Tenshi Holdings Pte. Ltd Director Other acquisition · Series A Convertible Preferred Stock +6,367 261,045
2018-03-23 Windisch Joerg Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2018-01-04 Mohan Pankaj President & CEO Sale −62,569 $1.16 $73K 7,056,553
2018-01-03 Mohan Pankaj President & CEO Sale −52,108 $1.18 $61K 7,119,122
2017-12-31 GMS Tenshi Holdings Pte. Ltd Director Other acquisition · Series A Convertible Preferred Stock +4,678 254,678
2017-12-22 Yamashita Elizabeth A. VP, Regulatory Affairs Sale −16,170 $1.13 $18K 64,648
2017-12-22 Bahrt Kenneth Chief Medical Officer Sale +26,165 $1.13 $30K 54,820
2017-12-22 MCANDREW STEPHEN J SVP Bus. Strat. & Dev. Sale +15,705 $1.13 $18K 50,899
2017-12-22 KENYON LAWRENCE A CFO and Secretary Sale −26,165 $1.13 $30K 67,313
2017-12-19 Mohan Pankaj President & CEO Sale −83,608 $1.14 $95K 7,171,230
2017-12-19 Yamashita Elizabeth A. VP, Regulatory Affairs Sale −6,151 $1.14 $7K 80,818
2017-12-18 Mohan Pankaj President & CEO Sale −20,523 $1.17 $24K 7,254,838
2017-12-18 Yamashita Elizabeth A. VP, Regulatory Affairs Sale −1,509 $1.17 $2K 86,969
2017-10-31 Albrecht Claudio Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2017-10-31 Haddadin Yezan Munther Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2017-10-31 Sukhtian Faisal Ghiath Director Grant or award · Stock Option (Right to Buy) +25,000 25,000

Page 17 of 20 · 386 trades